Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease ...

India approved its first dengue vaccine, Takeda's QDENGA, for ages 4–60. The two-dose vaccine protects against all four ...

Malaria remains overwhelmingly concentrated in poorer countries, where progress has slowed and children continue to bear the ...

India has approved Takeda's QDENGA, the country's first dengue vaccine. The shot protects against all four dengue virus ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It ...

The DCGI has approved Takeda's QDENGA, India’s first dengue vaccine, for ages 4-60 to combat rising dengue cases, ...

Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention ...

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing ...

India has taken a major step in the fight against dengue after the Central Drugs Standard Control Organisation (CDSCO) approved Takeda's QDENGA (TAK-003), ma ...

In a major step towards dengue prevention, the Central Drugs Standard Control Organisation (CDSCO) has approved Japanese drug ...

India approves its first dengue vaccine, QDENGA, for people aged 4 to 60, marking a major step in preventing dengue ...